Specialty Digest

Global English editionLearners’ Study Dashboard — in development
The Knowledge Library for All

World Cervical Cancer Elimination Day: A Cancer We Can End

A cancer with a known cause, a vaccine and a screening test, and a global plan to eliminate it by 2030.

Share
Link copied

All international days

Date
November 17, every year
Established
World Health Assembly resolution WHA78.8, May 27, 2025
Elimination threshold
4 or fewer cases per 100,000 women

Most cancers have no known single cause and no vaccine. Cervical cancer is different. Almost every case is caused by a common virus, a vaccine can prevent most of those infections, and a screening test can find the earliest warning signs years before a cancer forms. That combination is rare in medicine, and it is why the world has set itself an unusual goal: not just to treat cervical cancer, but to eliminate it as a public health problem. World Cervical Cancer Elimination Day, held every November 17, is the annual checkpoint on that promise. Like World Toilet Day, it asks the world to fix a problem we already know how to solve.

How a new day was born

The day grew out of a global strategy. In 2020, the World Health Organization launched its Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem, with the launch event held on November 17, 2020. The World Health Assembly had adopted that strategy through resolution WHA73.2. Five years later, member states turned the launch date into a yearly observance. On May 27, 2025, the Seventy-eighth World Health Assembly adopted resolution WHA78.8, urging member states to designate November 17 as World Cervical Cancer Elimination Day, to be observed each year commencing from November 2025.

The resolution gives the day practical jobs. It asks the WHO Director-General to use it to strengthen engagement with stakeholders, to strengthen population-based cancer registries, and to use vaccination and screening registries to measure progress toward the targets. It also notes that HPV vaccination coverage among girls under 15 is far from the goal of 90 percent by 2030. WHO called the 2025 observance the first World Cervical Cancer Elimination Day mandated by the World Health Assembly.

What “elimination” actually means

Eliminating a disease as a public health problem does not mean that no one ever gets it. For cervical cancer, WHO defines it as bringing new cases down to 4 or fewer per 100,000 women each year. The path to that line rests on three targets, all meant to be reached by 2030: 90 percent of girls fully vaccinated against human papillomavirus (HPV) by age 15, 70 percent of women screened with a high-performance test by age 35 and again by age 45, and 90 percent of women with precancer or cancer receiving treatment.

The 90-70-90 targets for 2030Three bars: 90 percent of girls vaccinated against HPV by age 15, 70 percent of women screened by 35 and again by 45, and 90 percent of women with precancer or cancer treated. The three targets for 2030 Girls vaccinated against HPV by age 15Women screened at 35 and again at 45Women with precancer or cancer treated 90%70%90%
The 90-70-90 targets to be achieved by 2030. Source: WHO, Cervical cancer fact sheet.

A cancer with a known cause

Almost all cervical cancer is caused by persistent infection with high-risk types of HPV, a very common virus spread through sexual contact. Most infections clear on their own. When one does not, abnormal cells can form and, over many years, can turn into cancer. WHO notes that HPV types 16 and 18 cause around 76 percent of cervical cancers. This slow timeline is the opportunity. Every stage offers a chance to step in.

Where each tool worksFrom HPV infection to persistent infection to precancer to cancer, with vaccination before infection, screening to find precancer, and treatment for precancer or cancer. From virus to cancer, and where to stop it HPV infectionPersistent infectionPrecancerCervical cancer Vaccinate girlsbefore exposureScreen, then treatthe precancerTreat the cancerearly and fully Vaccination ahead of infection is the strongest lever.
How the three targets map onto the course of the disease. Source: WHO, Global strategy to accelerate the elimination of cervical cancer.

Example 1: one town, three tools. Imagine a town of 10,000 girls and women. Vaccination protects the youngest before any exposure. Screening gives a woman in her thirties a test that finds a precancer while it is still small. A short outpatient treatment removes it. Each step works on a different person at a different age, which is why the strategy needs all three, not one.

The scale of the problem

WHO reports around 604,000 new cases of cervical cancer and around 280,000 deaths worldwide in 2024. These are modeled estimates, and they are revised as better data arrive. Behind the totals lies a stark pattern: the highest rates of illness and death are found in low- and middle-income countries, where vaccination, screening and treatment are hardest to reach. Women living with HIV are six times more likely to develop cervical cancer, and about 5 percent of cases are attributable to HIV.

Cervical cancer worldwide, 2024About 604,000 new cases and about 280,000 deaths estimated for 2024. Cervical cancer worldwide, 2024 New casesDeaths 604,000280,000 Modeled estimates, rounded by WHO.
Estimated new cases and deaths, 2024. Source: WHO, Cervical cancer fact sheet.

Example 2: the cost of waiting. Suppose a country has 1,000 women whose precancer is never found. If even a modest share go on to develop cancer, treatment will be far harder and costlier than a quick procedure at the precancer stage. The numbers are round and illustrative, but the logic is the heart of the strategy: finding trouble early is cheaper and kinder than treating it late.

Who gets left behind

Cervical cancer is a disease of inequality. Where girls can get the vaccine at school, where a clinic offers a screening test nearby, and where treatment is available without a long journey, rates fall. Where those services are missing, women are diagnosed late. That is why the day is about access as much as medicine. WHO recommends vaccinating girls at ages 9 to 14, and screening every 5 to 10 years from age 30, or every 3 to 5 years from age 25 for women living with HIV. In October 2024, WHO added an HPV vaccine for single-dose use, a change meant to make large campaigns simpler to run.

  • 90%of girls vaccinated by age 15, the 2030 target
  • 70%of women screened with a high-performance test, the 2030 target
  • 76%of cervical cancers caused by HPV types 16 and 18
  • 6 timeshigher risk for women living with HIV

How the first observance looked

On November 17, 2025, WHO described the first mandated observance as a moment when countries were accelerating action. Several launched or expanded HPV vaccination that year. Ghana ran a nationwide campaign in October 2025 for girls aged 9 to 14, aiming to reach 2.4 million girls. Pakistan introduced the vaccine nationally for girls aged 9 to 14, reaching over 9 million girls. Cuba launched in October 2025 for all girls in Grade 4, and Tunisia began a routine program for 12-year-old girls in April 2025. Nepal ran a nationwide campaign in February 2025 for girls aged 10 to 14, and China added the vaccine to its national immunization program, scaling up to all 13-year-old girls. Rwanda has set the 90-70-90 targets for 2027, and Indonesia has national targets of 90-75-90 under its plan for 2023 to 2030.

Example 3: a school campaign. Picture a district with 5,000 girls in the right age range. A school-based campaign that reaches 4,500 of them would cover 90 percent, which matches the vaccination target. The figures are round and illustrative. Real campaigns depend on schools, health workers, cold storage for vaccines and the trust of families.

How to mark the day

You do not need to be a doctor to take part. Check whether the girls in your family are vaccinated. If you are due for screening, make the appointment. Ask your health system whether it tracks vaccination and screening, because registries are exactly what the resolution asks countries to strengthen. And talk about it: a cancer that can be prevented should not be a quiet one. This article is general information, not medical advice, so please speak with a clinician about your own screening schedule.

Key Takeaways

  1. It is a day with a mission. The World Health Assembly set November 17 as the annual date in resolution WHA78.8, adopted May 27, 2025.
  2. Elimination has a number. The goal is 4 or fewer new cases per 100,000 women each year.
  3. Three targets, one plan. Vaccinate 90 percent of girls, screen 70 percent of women, treat 90 percent of those who need it, all by 2030.
  4. The cause is known. Persistent high-risk HPV infection drives almost all cases, and types 16 and 18 account for about 76 percent.
  5. The burden is large. WHO estimates about 604,000 new cases and 280,000 deaths in 2024.
  6. Access decides outcomes. The heaviest burden falls on low- and middle-income countries and on women living with HIV.
  7. You can act. Vaccinate on time, screen on schedule and ask how your community tracks both.

How solid is this? Case and death totals are modeled WHO estimates for 2024 and may be revised, and published WHO pages differ in how they rank and round some figures, so this article uses the fact sheet. Country details come from WHO’s November 2025 release. The three worked examples use round, made-up numbers to show an idea. See also the International Days hub and the International Days Calendar.

About the AuthorSpecialty Digest Editorial TeamEditorial StaffReporting and analysis from the Specialty Digest editorial team.
Share
Link copied